Literature DB >> 9059191

Neonatal abstinence syndrome due to codeine.

K Khan1, J Chang.   

Abstract

The neonatal abstinence syndrome (NAS) is a potentially life threatening illness associated with significant morbidity especially in the neonatal period. A case of NAS due to codeine prescribed for pain relief during pregnancy is reported. Clinicians should be aware that narcotic derivatives prescribed in late pregnancy can give rise to this type of problem.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9059191      PMCID： PMC1720606          DOI： 10.1136/fn.76.1.f59

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN： 1359-2998            Impact factor:   5.747


  5 in total

1.  Probable neonatal propoxyphene withdrawal: a case report.

Authors:  R B Klein; S Blatman; G A Little
Journal:  Pediatrics       Date:  1975-06       Impact factor: 7.124

2.  Neonatal opiate withdrawal.

Authors:  R P Rivers
Journal:  Arch Dis Child       Date:  1986-12       Impact factor: 3.791

3.  Neonatal codeine withdrawal in infants of nonaddicted mothers.

Authors:  H H Mangurten; R Benawra
Journal:  Pediatrics       Date:  1980-01       Impact factor: 7.124

4.  Narcotic withdrawal reaction in a newborn infant due to codeine.

Authors:  G Van Leeuwen; R Guthrie; F Stange
Journal:  Pediatrics       Date:  1965-10       Impact factor: 7.124

5.  Prospective study on the occurrence of withdrawal in critically ill children who receive fentanyl by continuous infusion.

Authors:  R Katz; H W Kelly; A Hsi
Journal:  Crit Care Med       Date:  1994-05       Impact factor: 7.598
  5 in total
  6 in total

1.  The use of central nervous system active drugs during pregnancy.

Authors:  Bengt Källén; Natalia Borg; Margareta Reis
Journal:  Pharmaceuticals (Basel)       Date:  2013-10-10

2.  Treating pain during pregnancy.

Authors:  Malaika Babb; Gideon Koren; Adrienne Einarson
Journal:  Can Fam Physician       Date:  2010-01       Impact factor: 3.275

3.  Use of prescribed opioid analgesics and co-medication with benzodiazepines in women before, during, and after pregnancy: a population-based cohort study.

Authors:  Marte Handal; Anders Engeland; Marit Rønning; Svetlana Skurtveit; Kari Furu
Journal:  Eur J Clin Pharmacol       Date:  2011-04-12       Impact factor: 2.953

Review 4.  Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.

Authors:  Irma Convertino; Alice Capogrosso Sansone; Alessandra Marino; Maria T Galiulo; Stefania Mantarro; Luca Antonioli; Matteo Fornai; Corrado Blandizzi; Marco Tuccori
Journal:  Drug Saf       Date:  2016-10       Impact factor: 5.606

5.  Neonatal withdrawal syndrome due to maternal codeine use.

Authors:  Vrinda Nair; Amuchou Singh Soraisham; Albert Akierman
Journal:  Paediatr Child Health       Date:  2012-05       Impact factor: 2.253

Review 6.  Safe prescribing practices in pregnancy and lactation.

Authors:  Wendy F Hansen; Anne E Peacock; Jerome Yankowitz
Journal:  J Midwifery Womens Health       Date:  2002 Nov-Dec       Impact factor: 2.388
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.